世界のアクティブ植込み型装置市場2021-2026:植込み型除細動器、植込み型心臓ペースメーカー、補助人工心臓、植込み型心臓モニター/植込み型ループレコーダー、神経刺激装置、植込み型聴覚装置

LP Informationが発行した調査報告書(LPI21MY8697)
◆英語タイトル:Global Active Implantable Devices Market Growth 2021-2026
◆商品コード:LPI21MY8697
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年5月(※2024年版があります。お問い合わせください)
◆ページ数:136
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療装置
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「アクティブ植込み型装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、植込み型除細動器、植込み型心臓ペースメーカー、補助人工心臓、植込み型心臓モニター/植込み型ループレコーダー、神経刺激装置、植込み型聴覚装置など、用途別には、病院、クリニックなどにセグメント区分してまとめました。アクティブ植込み型装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・アクティブ植込み型装置の世界市場概要(サマリー)
・アクティブ植込み型装置の企業別販売量・売上
・アクティブ植込み型装置の企業別市場シェア
・アクティブ植込み型装置の世界市場規模 2016年-2021年:種類別(植込み型除細動器、植込み型心臓ペースメーカー、補助人工心臓、植込み型心臓モニター/植込み型ループレコーダー、神経刺激装置、植込み型聴覚装置)
・アクティブ植込み型装置の世界市場規模 2016年-2021年:用途別(病院、クリニック)
・アクティブ植込み型装置の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・アクティブ植込み型装置のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・アクティブ植込み型装置のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・アクティブ植込み型装置の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・アクティブ植込み型装置市場の成長要因・課題・動向
・アクティブ植込み型装置の世界市場予測 2021年-2026年
・アクティブ植込み型装置の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・アクティブ植込み型装置のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・アクティブ植込み型装置のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・アクティブ植込み型装置の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・アクティブ植込み型装置の世界市場予測:種類別(植込み型除細動器、植込み型心臓ペースメーカー、補助人工心臓、植込み型心臓モニター/植込み型ループレコーダー、神経刺激装置、植込み型聴覚装置)
・アクティブ植込み型装置の世界市場予測:用途別(病院、クリニック)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Active Implantable Devices will have significant change from previous year. By the most conservative estimates of global Active Implantable Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Active Implantable Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Active Implantable Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Implantable Cardioverter Defibrillator
Implantable Cardiac Pacemakers
Ventricular Assist Devices
Implantable Heart Monitors/Insertable Loop Recorders
Neurostimulators
Implantable Hearing Devices

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
LivaNova PLC (U.K.)
MED-EL (Austria)
Medtronic (Ireland)
Abbott Laboratories (U.S.)
BIOTRONIK (Germany)
Boston Scientific Corporation (U.S.)
Cochlear Limited (Australia)
Nurotron Biotechnology (China)
Sonova Holding Switzerland)
William Demant Holding (Denmark)

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Active Implantable Devices Consumption 2016-2026
2.1.2 Active Implantable Devices Consumption CAGR by Region
2.2 Active Implantable Devices Segment by Type
2.2.1 Implantable Cardioverter Defibrillator
2.2.2 Implantable Cardiac Pacemakers
2.2.3 Ventricular Assist Devices
2.2.4 Implantable Heart Monitors/Insertable Loop Recorders
2.2.5 Neurostimulators
2.2.6 Implantable Hearing Devices
2.3 Active Implantable Devices Sales by Type
2.3.1 Global Active Implantable Devices Sales Market Share by Type (2016-2021)
2.3.2 Global Active Implantable Devices Revenue and Market Share by Type (2016-2021)
2.3.3 Global Active Implantable Devices Sale Price by Type (2016-2021)
2.4 Active Implantable Devices Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Active Implantable Devices Sales by Application
2.5.1 Global Active Implantable Devices Sale Market Share by Application (2016-2021)
2.5.2 Global Active Implantable Devices Revenue and Market Share by Application (2016-2021)
2.5.3 Global Active Implantable Devices Sale Price by Application (2016-2021)

3 Global Active Implantable Devices by Company
3.1 Global Active Implantable Devices Sales Market Share by Company
3.1.1 Global Active Implantable Devices Sales by Company (2019-2021)
3.1.2 Global Active Implantable Devices Sales Market Share by Company (2019-2021)
3.2 Global Active Implantable Devices Revenue Market Share by Company
3.2.1 Global Active Implantable Devices Revenue by Company (2019-2021)
3.2.2 Global Active Implantable Devices Revenue Market Share by Company (2019-2021)
3.3 Global Active Implantable Devices Sale Price by Company
3.4 Global Manufacturers Active Implantable Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Active Implantable Devices Product Location Distribution
3.4.2 Players Active Implantable Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Active Implantable Devices by Region
4.1 Global Active Implantable Devices by Region
4.1.1 Global Active Implantable Devices Sales by Region
4.1.2 Global Active Implantable Devices Revenue by Region
4.2 Americas Active Implantable Devices Sales Growth
4.3 APAC Active Implantable Devices Sales Growth
4.4 Europe Active Implantable Devices Sales Growth
4.5 Middle East & Africa Active Implantable Devices Sales Growth

5 Americas
5.1 Americas Active Implantable Devices Sales by Country
5.1.1 Americas Active Implantable Devices Sales by Country (2016-2021)
5.1.2 Americas Active Implantable Devices Revenue by Country (2016-2021)
5.2 Americas Active Implantable Devices Sales by Type
5.3 Americas Active Implantable Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Active Implantable Devices Sales by Region
6.1.1 APAC Active Implantable Devices Sales by Region (2016-2021)
6.1.2 APAC Active Implantable Devices Revenue by Region (2016-2021)
6.2 APAC Active Implantable Devices Sales by Type
6.3 APAC Active Implantable Devices Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Active Implantable Devices by Country
7.1.1 Europe Active Implantable Devices Sales by Country (2016-2021)
7.1.2 Europe Active Implantable Devices Revenue by Country (2016-2021)
7.2 Europe Active Implantable Devices Sales by Type
7.3 Europe Active Implantable Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Active Implantable Devices by Country
8.1.1 Middle East & Africa Active Implantable Devices Sales by Country (2016-2021)
8.1.2 Middle East & Africa Active Implantable Devices Revenue by Country (2016-2021)
8.2 Middle East & Africa Active Implantable Devices Sales by Type
8.3 Middle East & Africa Active Implantable Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Active Implantable Devices Distributors
10.3 Active Implantable Devices Customer

11 Global Active Implantable Devices Market Forecast
11.1 Global Active Implantable Devices Forecast by Region
11.1.1 Global Active Implantable Devices Forecast by Regions (2021-2026)
11.2.2 Global Active Implantable Devices Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Active Implantable Devices Forecast by Type
11.7 Global Active Implantable Devices Forecast by Application

12 Key Players Analysis
12.1 LivaNova PLC (U.K.)
12.1.1 LivaNova PLC (U.K.) LivaNova PLC (U.K.) Company Information
12.1.2 LivaNova PLC (U.K.) Active Implantable Devices Product Offered
12.1.3 LivaNova PLC (U.K.) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 LivaNova PLC (U.K.) Main Business Overview
12.1.5 LivaNova PLC (U.K.) Latest Developments
12.2 MED-EL (Austria)
12.2.1 MED-EL (Austria) Company Information
12.2.2 MED-EL (Austria) Active Implantable Devices Product Offered
12.2.3 MED-EL (Austria) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 MED-EL (Austria) Main Business Overview
12.2.5 MED-EL (Austria) Latest Developments
12.3 Medtronic (Ireland)
12.3.1 Medtronic (Ireland) Company Information
12.3.2 Medtronic (Ireland) Active Implantable Devices Product Offered
12.3.3 Medtronic (Ireland) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Medtronic (Ireland) Main Business Overview
12.3.5 Medtronic (Ireland) Latest Developments
12.4 Abbott Laboratories (U.S.)
12.4.1 Abbott Laboratories (U.S.) Company Information
12.4.2 Abbott Laboratories (U.S.) Active Implantable Devices Product Offered
12.4.3 Abbott Laboratories (U.S.) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Abbott Laboratories (U.S.) Main Business Overview
12.4.5 Abbott Laboratories (U.S.) Latest Developments
12.5 BIOTRONIK (Germany)
12.5.1 BIOTRONIK (Germany) Company Information
12.5.2 BIOTRONIK (Germany) Active Implantable Devices Product Offered
12.5.3 BIOTRONIK (Germany) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 BIOTRONIK (Germany) Main Business Overview
12.5.5 BIOTRONIK (Germany) Latest Developments
12.6 Boston Scientific Corporation (U.S.)
12.6.1 Boston Scientific Corporation (U.S.) Company Information
12.6.2 Boston Scientific Corporation (U.S.) Active Implantable Devices Product Offered
12.6.3 Boston Scientific Corporation (U.S.) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Boston Scientific Corporation (U.S.) Main Business Overview
12.6.5 Boston Scientific Corporation (U.S.) Latest Developments
12.7 Cochlear Limited (Australia)
12.7.1 Cochlear Limited (Australia) Company Information
12.7.2 Cochlear Limited (Australia) Active Implantable Devices Product Offered
12.7.3 Cochlear Limited (Australia) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Cochlear Limited (Australia) Main Business Overview
12.7.5 Cochlear Limited (Australia) Latest Developments
12.8 Nurotron Biotechnology (China)
12.8.1 Nurotron Biotechnology (China) Company Information
12.8.2 Nurotron Biotechnology (China) Active Implantable Devices Product Offered
12.8.3 Nurotron Biotechnology (China) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Nurotron Biotechnology (China) Main Business Overview
12.8.5 Nurotron Biotechnology (China) Latest Developments
12.9 Sonova Holding Switzerland)
12.9.1 Sonova Holding Switzerland) Company Information
12.9.2 Sonova Holding Switzerland) Active Implantable Devices Product Offered
12.9.3 Sonova Holding Switzerland) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Sonova Holding Switzerland) Main Business Overview
12.9.5 Sonova Holding Switzerland) Latest Developments
12.10 William Demant Holding (Denmark)
12.10.1 William Demant Holding (Denmark) Company Information
12.10.2 William Demant Holding (Denmark) Active Implantable Devices Product Offered
12.10.3 William Demant Holding (Denmark) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 William Demant Holding (Denmark) Main Business Overview
12.10.5 William Demant Holding (Denmark) Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Active Implantable Devices Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Implantable Cardioverter Defibrillator
Table 3. Major Players of Implantable Cardiac Pacemakers
Table 4. Major Players of Ventricular Assist Devices
Table 5. Major Players of Implantable Heart Monitors/Insertable Loop Recorders
Table 6. Major Players of Neurostimulators
Table 7. Major Players of Implantable Hearing Devices
Table 8. Global Active Implantable Devices Sales by Type (2016-2021) & (K Units)
Table 9. Global Active Implantable Devices Sales Market Share by Type (2016-2021)
Table 10. Global Active Implantable Devices Revenue by Type (2016-2021) & ($ million)
Table 11. Global Active Implantable Devices Revenue Market Share by Type (2016-2021)
Table 12. Global Active Implantable Devices Sale Price by Type (2016-2021)
Table 13. Global Active Implantable Devices Sales by Application (2016-2021) & (K Units)
Table 14. Global Active Implantable Devices Sales Market Share by Application (2016-2021)
Table 15. Global Active Implantable Devices Value by Application (2016-2021)
Table 16. Global Active Implantable Devices Revenue Market Share by Application (2016-2021)
Table 17. Global Active Implantable Devices Sale Price by Application (2016-2021)
Table 18. Global Active Implantable Devices Sales by Company (2019-2021) & (K Units)
Table 19. Global Active Implantable Devices Sales Market Share by Company (2019-2021)
Table 20. Global Active Implantable Devices Revenue by Company (2019-2021) ($ Millions)
Table 21. Global Active Implantable Devices Revenue Market Share by Company (2019-2021)
Table 22. Global Active Implantable Devices Sale Price by Company (2019-2021)
Table 23. Key Manufacturers Active Implantable Devices Producing Area Distribution and Sales Area
Table 24. Players Active Implantable Devices Products Offered
Table 25. Active Implantable Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Active Implantable Devices Sales by Region (2016-2021) (K Units)
Table 29. Global Active Implantable Devices Sales Market Share by Region (2016-2021)
Table 30. Global Active Implantable Devices Revenue by Region (2016-2021) & ($ Millions)
Table 31. Global Active Implantable Devices Revenue Market Share by Region (2016-2021)
Table 32. Americas Active Implantable Devices Sales by Country (2016-2021) & (K Units)
Table 33. Americas Active Implantable Devices Sales Market Share by Country (2016-2021)
Table 34. Americas Active Implantable Devices Revenue by Country (2016-2021) & ($ Millions)
Table 35. Americas Active Implantable Devices Revenue Market Share by Country (2016-2021)
Table 36. Americas Active Implantable Devices Sales by Type (2016-2021) & (K Units)
Table 37. Americas Active Implantable Devices Sales Market Share by Type (2016-2021)
Table 38. Americas Active Implantable Devices Sales by Application (2016-2021) & (K Units)
Table 39. Americas Active Implantable Devices Sales Market Share by Application (2016-2021)
Table 40. APAC Active Implantable Devices Sales by Region (2016-2021) & (K Units)
Table 41. APAC Active Implantable Devices Sales Market Share by Region (2016-2021)
Table 42. APAC Active Implantable Devices Revenue by Region (2016-2021) & ($ Millions)
Table 43. APAC Active Implantable Devices Revenue Market Share by Region (2016-2021)
Table 44. APAC Active Implantable Devices Sales by Type (2016-2021) & (K Units)
Table 45. APAC Active Implantable Devices Sales Market Share by Type (2016-2021)
Table 46. APAC Active Implantable Devices Sales by Application (2016-2021) & (K Units)
Table 47. APAC Active Implantable Devices Sales Market Share by Application (2016-2021)
Table 48. Europe Active Implantable Devices Sales by Country (2016-2021) & (K Units)
Table 49. Europe Active Implantable Devices Sales Market Share by Country (2016-2021)
Table 50. Europe Active Implantable Devices Revenue by Country (2016-2021) & ($ Millions)
Table 51. Europe Active Implantable Devices Revenue Market Share by Country (2016-2021)
Table 52. Europe Active Implantable Devices Sales by Type (2016-2021) & (K Units)
Table 53. Europe Active Implantable Devices Sales Market Share by Type (2016-2021)
Table 54. Europe Active Implantable Devices Sales by Application (2016-2021) & (K Units)
Table 55. Europe Active Implantable Devices Sales Market Share by Application (2016-2021)
Table 56. Middle East & Africa Active Implantable Devices Sales by Country (2016-2021) & (K Units)
Table 57. Middle East & Africa Active Implantable Devices Sales Market Share by Country (2016-2021)
Table 58. Middle East & Africa Active Implantable Devices Revenue by Country (2016-2021) & ($ Millions)
Table 59. Middle East & Africa Active Implantable Devices Revenue Market Share by Country (2016-2021)
Table 60. Middle East & Africa Active Implantable Devices Sales by Type (2016-2021) & (K Units)
Table 61. Middle East & Africa Active Implantable Devices Sales Market Share by Type (2016-2021)
Table 62. Middle East & Africa Active Implantable Devices Sales by Application (2016-2021) & (K Units)
Table 63. Middle East & Africa Active Implantable Devices Sales Market Share by Application (2016-2021)
Table 64. Global Active Implantable Devices Sales Forecast by Type (2021-2026) & (K Units)
Table 65. Global Active Implantable Devices Sales Market Share Forecast by Type (2021-2026)
Table 66. Global Active Implantable Devices Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 67. Global Active Implantable Devices Revenue Market Share Forecast by Type (2021-2026)
Table 68. Global Active Implantable Devices Sales Forecast by Application (2021-2026) & (K Units)
Table 69. Global Active Implantable Devices Sales Market Share Forecast by Application (2021-2026)
Table 70. Global Active Implantable Devices Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 71. Global Active Implantable Devices Revenue Market Share Forecast by Application (2021-2026)
Table 72. LivaNova PLC (U.K.) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 73. LivaNova PLC (U.K.) Active Implantable Devices Product Offered
Table 74. LivaNova PLC (U.K.) Active Implantable Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 75. LivaNova PLC (U.K.) Main Business
Table 76. LivaNova PLC (U.K.) Latest Developments
Table 77. MED-EL (Austria) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 78. MED-EL (Austria) Active Implantable Devices Product Offered
Table 79. MED-EL (Austria) Active Implantable Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 80. MED-EL (Austria) Main Business
Table 81. MED-EL (Austria) Latest Developments
Table 82. Medtronic (Ireland) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 83. Medtronic (Ireland) Active Implantable Devices Product Offered
Table 84. Medtronic (Ireland) Active Implantable Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 85. Medtronic (Ireland) Main Business
Table 86. Medtronic (Ireland) Latest Developments
Table 87. Abbott Laboratories (U.S.) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 88. Abbott Laboratories (U.S.) Active Implantable Devices Product Offered
Table 89. Abbott Laboratories (U.S.) Active Implantable Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 90. Abbott Laboratories (U.S.) Main Business
Table 91. Abbott Laboratories (U.S.) Latest Developments
Table 92. BIOTRONIK (Germany) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 93. BIOTRONIK (Germany) Active Implantable Devices Product Offered
Table 94. BIOTRONIK (Germany) Active Implantable Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 95. BIOTRONIK (Germany) Main Business
Table 96. BIOTRONIK (Germany) Latest Developments
Table 97. Boston Scientific Corporation (U.S.) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. Boston Scientific Corporation (U.S.) Active Implantable Devices Product Offered
Table 99. Boston Scientific Corporation (U.S.) Active Implantable Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 100. Boston Scientific Corporation (U.S.) Main Business
Table 101. Boston Scientific Corporation (U.S.) Latest Developments
Table 102. Cochlear Limited (Australia) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. Cochlear Limited (Australia) Active Implantable Devices Product Offered
Table 104. Cochlear Limited (Australia) Active Implantable Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 105. Cochlear Limited (Australia) Main Business
Table 106. Cochlear Limited (Australia) Latest Developments
Table 107. Nurotron Biotechnology (China) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. Nurotron Biotechnology (China) Active Implantable Devices Product Offered
Table 109. Nurotron Biotechnology (China) Active Implantable Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 110. Nurotron Biotechnology (China) Main Business
Table 111. Nurotron Biotechnology (China) Latest Developments
Table 112. Sonova Holding Switzerland) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. Sonova Holding Switzerland) Active Implantable Devices Product Offered
Table 114. Sonova Holding Switzerland) Active Implantable Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 115. Sonova Holding Switzerland) Main Business
Table 116. Sonova Holding Switzerland) Latest Developments
Table 117. William Demant Holding (Denmark) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. William Demant Holding (Denmark) Active Implantable Devices Product Offered
Table 119. William Demant Holding (Denmark) Active Implantable Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 120. William Demant Holding (Denmark) Main Business
Table 121. William Demant Holding (Denmark) Latest Developments
List of Figures
Figure 1. Picture of Active Implantable Devices
Figure 2. Active Implantable Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Active Implantable Devices Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Active Implantable Devices Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Active Implantable Devices Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Implantable Cardioverter Defibrillator
Figure 10. Product Picture of Implantable Cardiac Pacemakers
Figure 11. Product Picture of Ventricular Assist Devices
Figure 12. Product Picture of Implantable Heart Monitors/Insertable Loop Recorders
Figure 13. Product Picture of Neurostimulators
Figure 14. Product Picture of Implantable Hearing Devices
Figure 15. Global Active Implantable Devices Sales Market Share by Type in 2020
Figure 16. Global Active Implantable Devices Revenue Market Share by Type (2016-2021)
Figure 17. Active Implantable Devices Consumed in Hospital
Figure 18. Global Active Implantable Devices Market: Hospital (2016-2021) & (K Units)
Figure 19. Active Implantable Devices Consumed in Clinic
Figure 20. Global Active Implantable Devices Market: Clinic (2016-2021) & (K Units)
Figure 21. Global Active Implantable Devices Sales Market Share by Application (2016-2021)
Figure 22. Global Active Implantable Devices Revenue Market Share by Application in 2020
Figure 23. Global Active Implantable Devices Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Active Implantable Devices Revenue Market Share by Company in 2020
Figure 25. Global Active Implantable Devices Sales Market Share by Regions (2016-2021)
Figure 26. Global Active Implantable Devices Revenue Market Share by Region in 2020
Figure 27. Americas Active Implantable Devices Sales 2016-2021 (K Units)
Figure 28. Americas Active Implantable Devices Revenue 2016-2021 ($ Millions)
Figure 29. APAC Active Implantable Devices Sales 2016-2021 (K Units)
Figure 30. APAC Active Implantable Devices Revenue 2016-2021 ($ Millions)
Figure 31. Europe Active Implantable Devices Sales 2016-2021 (K Units)
Figure 32. Europe Active Implantable Devices Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Active Implantable Devices Sales 2016-2021 (K Units)
Figure 34. Middle East & Africa Active Implantable Devices Revenue 2016-2021 ($ Millions)
Figure 35. Americas Active Implantable Devices Sales Market Share by Country in 2020
Figure 36. Americas Active Implantable Devices Revenue Market Share by Country in 2020
Figure 37. Americas Active Implantable Devices Sales Market Share by Type in 2020
Figure 38. Americas Active Implantable Devices Sales Market Share by Application in 2020
Figure 39. United States Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Active Implantable Devices Sales Market Share by Region in 2020
Figure 44. APAC Active Implantable Devices Revenue Market Share by Regions in 2020
Figure 45. APAC Active Implantable Devices Sales Market Share by Type in 2020
Figure 46. APAC Active Implantable Devices Sales Market Share by Application in 2020
Figure 47. China Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Active Implantable Devices Sales Market Share by Country in 2020
Figure 54. Europe Active Implantable Devices Revenue Market Share by Country in 2020
Figure 55. Europe Active Implantable Devices Sales Market Share by Type in 2020
Figure 56. Europe Active Implantable Devices Sales Market Share by Application in 2020
Figure 57. Germany Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Active Implantable Devices Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Active Implantable Devices Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Active Implantable Devices Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Active Implantable Devices Sales Market Share by Application in 2020
Figure 66. Egypt Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Active Implantable Devices Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のアクティブ植込み型装置市場2021-2026:植込み型除細動器、植込み型心臓ペースメーカー、補助人工心臓、植込み型心臓モニター/植込み型ループレコーダー、神経刺激装置、植込み型聴覚装置(Global Active Implantable Devices Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。